ARQ-151 cream 0.05%

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic DermatitisNCT06998056ARQTPhase 2Completed2025-12-04Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.